Logo image of DAP.DE

DANAHER CORP (DAP.DE) Stock Fundamental Analysis

Europe - FRA:DAP - US2358511028 - Common Stock

184 EUR
+2.82 (+1.56%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, DAP scores 6 out of 10 in our fundamental rating. DAP was compared to 20 industry peers in the Life Sciences Tools & Services industry. DAP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, DAP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

DAP had positive earnings in the past year.
In the past year DAP had a positive cash flow from operations.
DAP had positive earnings in each of the past 5 years.
In the past 5 years DAP always reported a positive cash flow from operatings.
DAP.DE Yearly Net Income VS EBIT VS OCF VS FCFDAP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

DAP's Return On Assets of 4.18% is fine compared to the rest of the industry. DAP outperforms 66.67% of its industry peers.
With a Return On Equity value of 6.52%, DAP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Return On Invested Capital of DAP (5.32%) is comparable to the rest of the industry.
DAP had an Average Return On Invested Capital over the past 3 years of 6.76%. This is in line with the industry average of 7.27%.
Industry RankSector Rank
ROA 4.18%
ROE 6.52%
ROIC 5.32%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
DAP.DE Yearly ROA, ROE, ROICDAP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

DAP has a Profit Margin of 14.21%. This is in the better half of the industry: DAP outperforms 77.78% of its industry peers.
In the last couple of years the Profit Margin of DAP has remained more or less at the same level.
DAP's Operating Margin of 19.79% is amongst the best of the industry. DAP outperforms 83.33% of its industry peers.
In the last couple of years the Operating Margin of DAP has grown nicely.
Looking at the Gross Margin, with a value of 59.72%, DAP belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of DAP has remained more or less at the same level.
Industry RankSector Rank
OM 19.79%
PM (TTM) 14.21%
GM 59.72%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
DAP.DE Yearly Profit, Operating, Gross MarginsDAP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DAP is destroying value.
The number of shares outstanding for DAP has been reduced compared to 1 year ago.
DAP has more shares outstanding than it did 5 years ago.
DAP has a better debt/assets ratio than last year.
DAP.DE Yearly Shares OutstandingDAP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DAP.DE Yearly Total Debt VS Total AssetsDAP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 4.49 indicates that DAP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.49, DAP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
DAP has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as DAP would need 3.57 years to pay back of all of its debts.
DAP's Debt to FCF ratio of 3.57 is fine compared to the rest of the industry. DAP outperforms 77.78% of its industry peers.
DAP has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
DAP's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. DAP outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.57
Altman-Z 4.49
ROIC/WACC0.53
WACC10.07%
DAP.DE Yearly LT Debt VS Equity VS FCFDAP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 1.62 indicates that DAP should not have too much problems paying its short term obligations.
DAP has a Current ratio of 1.62. This is in the better half of the industry: DAP outperforms 72.22% of its industry peers.
DAP has a Quick Ratio of 1.22. This is a normal value and indicates that DAP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DAP (1.22) is better than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.22
DAP.DE Yearly Current Assets VS Current LiabilitesDAP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The earnings per share for DAP have decreased by -2.84% in the last year.
The Earnings Per Share has been growing by 9.77% on average over the past years. This is quite good.
Looking at the last year, DAP shows a small growth in Revenue. The Revenue has grown by 1.89% in the last year.
Measured over the past years, DAP shows a small growth in Revenue. The Revenue has been growing by 5.92% on average per year.
EPS 1Y (TTM)-2.84%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%4.65%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%3.36%

3.2 Future

The Earnings Per Share is expected to grow by 9.65% on average over the next years. This is quite good.
Based on estimates for the next years, DAP will show a small growth in Revenue. The Revenue will grow by 5.81% on average per year.
EPS Next Y4.85%
EPS Next 2Y7.59%
EPS Next 3Y8.47%
EPS Next 5Y9.65%
Revenue Next Year3.84%
Revenue Next 2Y4.88%
Revenue Next 3Y5.59%
Revenue Next 5Y5.81%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DAP.DE Yearly Revenue VS EstimatesDAP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
DAP.DE Yearly EPS VS EstimatesDAP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.66 indicates a quite expensive valuation of DAP.
Compared to the rest of the industry, the Price/Earnings ratio of DAP is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.86. DAP is around the same levels.
A Price/Forward Earnings ratio of 24.90 indicates a rather expensive valuation of DAP.
DAP's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, DAP is valued at the same level.
Industry RankSector Rank
PE 28.66
Fwd PE 24.9
DAP.DE Price Earnings VS Forward Price EarningsDAP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DAP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DAP is more expensive than 66.67% of the companies in the same industry.
DAP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.8
EV/EBITDA 23.67
DAP.DE Per share dataDAP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DAP does not grow enough to justify the current Price/Earnings ratio.
DAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.9
PEG (5Y)2.93
EPS Next 2Y7.59%
EPS Next 3Y8.47%

5

5. Dividend

5.1 Amount

DAP has a yearly dividend return of 0.61%, which is pretty low.
Compared to an average industry Dividend Yield of 0.71, DAP pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.61, DAP pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

The dividend of DAP is nicely growing with an annual growth rate of 6.91%!
Dividend Growth(5Y)6.91%
Div Incr Years5
Div Non Decr Years5
DAP.DE Yearly Dividends per shareDAP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

23.85% of the earnings are spent on dividend by DAP. This is a low number and sustainable payout ratio.
The dividend of DAP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.85%
EPS Next 2Y7.59%
EPS Next 3Y8.47%
DAP.DE Yearly Income VS Free CF VS DividendDAP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
DAP.DE Dividend Payout.DAP.DE Dividend Payout, showing the Payout Ratio.DAP.DE Dividend Payout.PayoutRetained Earnings

DANAHER CORP

FRA:DAP (10/3/2025, 7:00:00 PM)

184

+2.82 (+1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-21 2025-10-21/amc
Inst Owners82.47%
Inst Owner ChangeN/A
Ins Owners10.82%
Ins Owner ChangeN/A
Market Cap131.75B
Analysts86.21
Price Target208.74 (13.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.9
Dividend Growth(5Y)6.91%
DP23.85%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.86%
Min EPS beat(2)8.42%
Max EPS beat(2)13.3%
EPS beat(4)3
Avg EPS beat(4)6.93%
Min EPS beat(4)-1.93%
Max EPS beat(4)13.3%
EPS beat(8)7
Avg EPS beat(8)7.86%
EPS beat(12)11
Avg EPS beat(12)7.64%
EPS beat(16)15
Avg EPS beat(16)7.84%
Revenue beat(2)2
Avg Revenue beat(2)1.19%
Min Revenue beat(2)0.68%
Max Revenue beat(2)1.7%
Revenue beat(4)4
Avg Revenue beat(4)1.45%
Min Revenue beat(4)0.66%
Max Revenue beat(4)2.75%
Revenue beat(8)8
Avg Revenue beat(8)1.98%
Revenue beat(12)9
Avg Revenue beat(12)-4.19%
Revenue beat(16)12
Avg Revenue beat(16)-6.15%
PT rev (1m)-1.73%
PT rev (3m)-3.98%
EPS NQ rev (1m)-0.58%
EPS NQ rev (3m)-4.46%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 28.66
Fwd PE 24.9
P/S 6.44
P/FCF 31.8
P/OCF 25.06
P/B 2.95
P/tB N/A
EV/EBITDA 23.67
EPS(TTM)6.42
EY3.49%
EPS(NY)7.39
Fwd EY4.02%
FCF(TTM)5.79
FCFY3.14%
OCF(TTM)7.34
OCFY3.99%
SpS28.58
BVpS62.29
TBVpS-11.05
PEG (NY)5.9
PEG (5Y)2.93
Profitability
Industry RankSector Rank
ROA 4.18%
ROE 6.52%
ROCE 6.35%
ROIC 5.32%
ROICexc 5.54%
ROICexgc 38.86%
OM 19.79%
PM (TTM) 14.21%
GM 59.72%
FCFM 20.25%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
ROICexc(3y)7.22%
ROICexc(5y)6.94%
ROICexgc(3y)54.83%
ROICexgc(5y)57.37%
ROCE(3y)8.07%
ROCE(5y)7.78%
ROICexcg growth 3Y-10.53%
ROICexcg growth 5Y-4.54%
ROICexc growth 3Y-4.88%
ROICexc growth 5Y-2.88%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.57
Debt/EBITDA 2.36
Cap/Depr 54.73%
Cap/Sales 5.44%
Interest Coverage 13.86
Cash Conversion 86.39%
Profit Quality 142.46%
Current Ratio 1.62
Quick Ratio 1.22
Altman-Z 4.49
F-Score7
WACC10.07%
ROIC/WACC0.53
Cap/Depr(3y)58.29%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.31%
Cap/Sales(5y)4.94%
Profit Quality(3y)120.48%
Profit Quality(5y)125.69%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.84%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%4.65%
EPS Next Y4.85%
EPS Next 2Y7.59%
EPS Next 3Y8.47%
EPS Next 5Y9.65%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%3.36%
Revenue Next Year3.84%
Revenue Next 2Y4.88%
Revenue Next 3Y5.59%
Revenue Next 5Y5.81%
EBIT growth 1Y-6.03%
EBIT growth 3Y-6.57%
EBIT growth 5Y9.77%
EBIT Next Year11.5%
EBIT Next 3Y9.71%
EBIT Next 5Y9.96%
FCF growth 1Y-32.49%
FCF growth 3Y-9.16%
FCF growth 5Y9.82%
OCF growth 1Y-26.77%
OCF growth 3Y-7.16%
OCF growth 5Y11.1%